The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2016

Filed:

Oct. 04, 2011
Applicants:

Shuji Matsuoka, Bunkyo-ku, JP;

Yasuyuki Ishii, Minoo, JP;

Inventors:

Shuji Matsuoka, Bunkyo-ku, JP;

Yasuyuki Ishii, Minoo, JP;

Assignees:

RIKEN, Wako-shi, JP;

JUNTENDO EDUCATIONAL FOUNDATION, Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/18 (2006.01); C07K 16/30 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); C07K 16/2803 (2013.01); C07K 16/30 (2013.01); C07K 2317/34 (2013.01); G01N 2333/70539 (2013.01);
Abstract

Provided is a novel therapeutic agent specific for a malignant tumor expressing MHC class II. The present invention provides an antibody recognizing a protein constituting MHC class II expressed on a malignant tumor, the antibody comprising at least one selected from heavy chain CDR1 (amino acid sequence represented by positions 49 to 54 of SEQ ID NO: 54), heavy chain CDR2 (amino acid sequence represented by positions 69 to 84 of SEQ ID NO: 54), heavy chain CDR3 (amino acid sequence represented by positions 117 to 128 of SEQ ID NO: 54), light chain CDR1 (amino acid sequence represented by positions 46 to 55 of SEQ ID NO: 56), light chain CDR2 (amino acid sequence represented by positions 71 to 77 of SEQ ID NO: 56), and light chain CDR3 (amino acid sequence represented by positions 100 to 108 of SEQ ID NO: 56).


Find Patent Forward Citations

Loading…